Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT01816698

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Zhiming Zhu (from the registry)
Registry
  • NCT NCT01816698
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01816698. Randomized; quadruple masking; primary purpose prevention. Start 2012-12 (registry gives no type); primary completion 2015-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
Acronym
ESTAB
Condition
Prehypertension
Intervention (Drug)
Taurine granule
Intervention (Drug)
Placebo
Lead sponsor
Zhiming Zhu (class: other)

Record details

Record id
cardio:ct-nct01816698
Content hash
9d8c612e42ec4e45660546bc06a9e6d48f3e15d2371139982b91098cf3fe2e02